The filing of the preliminary proxy statement follows the trading suspension of the Company’s common stock due to non-compliance with Nasdaq’s minimum bid price requirements. Vaxart appealed the ...

One of the main factors determining therapeutic antibodies’ half-life is the interaction between the antibody’s Fc region and ...

The National Medical Products Administration (NMPA) approved an investigational new drug (IND) application for WIN378 to ...

Learn how antibody-drug conjugates are advancing therapies for non-cancer conditions, unlocking new possibilities in ...

Research and development collaboration program to include additional models of lymphoma and leukemia to further validate DNase-I data demonstrated to date ...

The U.S. Food and Drug Administration has approved GSK's prefilled syringe presentation of Shingrix (zoster vaccine ...

With global food systems threatened by crop uniformity and climate stress, scientists are turning to the rich genetic ...

Pediatric and adult patients experienced noninferior and robust immune responses to RIV4, as well as similar safety profiles.

Misperceptions around a vaccine’s plaque-forming unit (PFU) level are leading to inaccurate conclusions about vaccine protection ...

India's ICMR has developed AdFalciVax, a recombinant malaria vaccine targeting two critical stages of Plasmodium falciparum. Showing promise in preclinical trials, it aims to reduce transmission and ...

The Indian Council of Medical Research (ICMR), through its Regional Medical Research Centre, Bhubaneswar (RMRCBB) and ...

The U.S. FDA has approved a prefilled syringe presentation of GSK plc’s SHINGRIX for the prevention of shingles.